Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250625 | 7036941 | I | 6250625-6 | 20031001 | 20090624 | 20090630 | EXP | US-ASTRAZENECA-2008UW24335 | AZPRODUW00 | 678 | MON | F | Y | 77.1 | KG | 20090630 | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250625 | 1011812025 | PS | SEROQUEL | 1 | ORAL | 25 MG; 1 MORNING, 3-4 MORE FOR EVENING | 020639 | ||||
| 6250625 | 1011812026 | C | ZYPREXA | 1 | |||||||
| 6250625 | 1011812027 | C | LEXAPRO | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6250625 | 1011812025 | DEPRESSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6250625 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6250625 | BACK PAIN |
| 6250625 | BLOOD CHOLESTEROL INCREASED |
| 6250625 | BLOOD TRIGLYCERIDES INCREASED |
| 6250625 | DIABETES MELLITUS |
| 6250625 | GALLBLADDER DISORDER |
| 6250625 | OBESITY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6250625 | 1011812025 | 20030901 | 20040901 | 12 | MON |
| 6250625 | 1011812026 | 20030703 | 4 | WK | |
| 6250625 | 1011812027 | 20030702 |